申请人:Hayakawa Masahiko
                            
                            
                                公开号:US20060205770A1
                            
                            
                                公开(公告)日:2006-09-14
                            
                            There is provided an acid addition salt of (−)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate with an acid selected from the group consisting of (−)-(2S,3S)-tartaric acid, (+)-(2S,3S)-di-O-benzoyltartaric acid, (+)-(2S,3S)-di-O-(4-methylbenzoyl)tartaric acid, (−)-L-phenylalanine, benzenesulfonic acid, cyclohexanesulfamic acid, hydrobromic acid, naphthalene-2-sulfonic acid, sebacic acid, (+)-camphor-10-sulfonic acid, p-toluenesulfonic acid, ethanesulfonic acid, methanesulfonic acid and methyl phosphate, which has little hygroscopicity that affects the use as a drug or its drug substance, and is very useful as a drug or its drug substance.
                            提供了(-)-(3R)-喹
硫脒-3-基(1R)-
1-苯基-1,2,3,4-四氢异喹啉-2-
羧酸盐,与以下酸之一选择的酸形成盐:(-)-(2S,3S)-
酒石酸,(+)-(2S,3S)-二-O-苯甲酰
酒石酸,(+)-(2S,3S)-二-O-(4-甲基苯甲酰)
酒石酸,(-)-
L-苯丙氨酸,
苯磺酸,环己
磺酸,
氢溴酸,
萘-2-磺酸,
癸二酸,(+)-
樟脑-10-
磺酸,
对甲苯磺酸,
乙烷磺酸,
甲烷磺酸和
磷酸甲酯。该盐具有很少的吸湿性,不影响其作为药物或药物成分的使用,非常适用作为药物或药物成分。